Hylly
Henkilönnimi
Nimeke- ja vastuullisuusmerkintö An update on research- and bolar exemptions in the U.S. and Europe : unsolved questions and potential scenarios in an increasingly important area of law
Julkaistu
Ulkoasutiedot
Sarjamerkintö ei-lisäkirjausmuodossa NIR : Nordiskt immateriellt rättsskydd, ISSN 0027-6723 ; 88 (2)
Huomautus sisällöstä, tiivistelmä tms. Focusing on pharmaceutical technology, this article provides a basic overview of the background of the exemptions to patent protection provided by Bolar type-provisions and research exemptions in the EU and US, and examines their intersection with relevant TRIPS provisions. Furthermore, it provides an overview and discussion of unresolved issues and possible future developments in this increasingly important and exciting area of law. To achieve these goals, we will start out with a brief description of the general background of the topic (2). Next, we will summarize the current U.S. perspective on available exemptions for use of patented inventions considering the common law and the statutory exemptions from infringement (3). This is followed by a brief overview of the corresponding situation in Europe, including a presentation of some of the unresolved issues pertaining to the application and interpretation of the exemptions (4). This provides the basis for a discussion of some of the nascent trends addressing the challenges (5) which will finally allow us to conclude the paper with some final remarks (6).
Asiasana
Henkilönnimi
Sarjalisäkirjaus - yhtenäistetty nimeke NIR : Nordiskt immateriellt rättsskydd, 0027-6723 ; 88 (2)
*00001992nab a22002534a 4500
*00113975
*00520201106111845.0
*007tu
*008191031s2019\\\\xx\|||||\||||\|||||0eng|c
*035 $a26739
*035 $a(PLib-conv)0000026739
*0410 $aeng
*090 $aOMA:SA-NO20
*1001 $aMinssen, Timo.
*24510$aAn update on research- and bolar exemptions in the U.S. and Europe :$bunsolved questions and potential scenarios in an increasingly important area of law /$cTimo Minssen, Jakob Wested.
*260 $c2019.
*300 $a168-183.
*4901 $aNIR : Nordiskt immateriellt rättsskydd,$x0027-6723 ;$v88 (2)
*520 $aFocusing on pharmaceutical technology, this article provides a basic overview of the background of the exemptions to patent protection provided by Bolar type-provisions and research exemptions in the EU and US, and examines their intersection with relevant TRIPS provisions. Furthermore, it provides an overview and discussion of unresolved issues and possible future developments in this increasingly important and exciting area of law. To achieve these goals, we will start out with a brief description of the general background of the topic (2). Next, we will summarize the current U.S. perspective on available exemptions for use of patented inventions considering the common law and the statutory exemptions from infringement (3). This is followed by a brief overview of the corresponding situation in Europe, including a presentation of some of the unresolved issues pertaining to the application and interpretation of the exemptions (4). This provides the basis for a discussion of some of the nascent trends addressing the challenges (5) which will finally allow us to conclude the paper with some final remarks (6).
*650 7$alääketeollisuus $0http://www.yso.fi/onto/yso/p11187$2yso/fin
*650 7$apatentit$0http://www.yso.fi/onto/yso/p3069$2yso/fin
*7001 $aWested, Jakob.
*830 0$aNIR : Nordiskt immateriellt rättsskydd,$x0027-6723 ;$v88 (2)
*852 $hSA-NO20$cMINSSEN
*979 $a0000026739
*999 $aMikroMarc$b[Article]$x7
^
Tästä teoksesta ei ole arvioita.
Näpäytä
kun haluat kirjoittaa ensimmäisen arvion.